Short-term marketable securities (amortized cost of 174,510 and 156,246, respectively)
174,382
140,753
156,485
157,735
Accounts receivable, net
49,513
48,315
50,365
44,821
Inventory
10,497
11,206
9,820
9,933
Prepaid expenses and other current assets
16,298
13,952
13,020
13,912
Total current assets
420,563
291,807
300,185
281,435
Property and equipment, at cost
-
-
129,893
-
Less accumulated depreciation
-
-
95,786
-
Property and equipment, net
29,451
30,774
34,107
37,498
Operating lease right-of-use assets
39,122
40,248
40,616
41,988
Long-term marketable securities (amortized cost of 27,564 and 13,220, respectively)
27,480
18,889
13,234
4,037
Restricted cash
2,728
2,709
2,689
2,689
Gross carrying amount
-
-
20,325
-
Accumulated amortization
-
-
18,599
-
Intangible assets, net
884
1,307
1,726
2,155
Goodwill
118,972
118,972
118,972
118,972
Other assets
1,478
1,237
1,207
1,836
Total assets
640,678
505,943
512,736
490,610
Accounts payable
5,241
9,615
6,467
10,267
Accrued liabilities
10,651
7,465
7,700
7,205
Accrued compensation and benefits
9,742
6,217
16,992
12,681
Current portion of operating lease liabilities
8,823
8,513
8,920
9,442
Current portion of deferred revenue
53,255
49,397
45,194
41,337
Current portion of revenue interest liability, net
0
5,804
4,642
2,429
Total current liabilities
87,712
87,011
89,915
83,361
Operating lease liabilities, less current portion
66,800
69,115
70,228
72,361
Deferred revenue, less current portion
608
807
1,006
1,206
Revenue interest liability, net, less current portion
0
124,749
126,566
129,409
Convertible senior notes, net
334,876
-
-
-
Other long-term liabilities
20
20
20
20
Total liabilities
490,016
281,702
287,735
286,357
Common stock 0.0001 par value, 340,000,000 shares authorized at june 30, 2026 and december 31, 2025 159,059,622 and 153,779,418 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
16
16
15
15
Additional paid-in capital
1,566,254
1,599,708
1,581,848
1,553,953
Accumulated other comprehensive (loss) gain
-212
-28
253
211
Accumulated deficit
-1,423,144
-1,383,356
-1,363,323
-1,349,744
Total adaptive biotechnologies corporation shareholders equity
142,914
216,340
218,793
204,435
Noncontrolling interest
7,748
7,901
6,208
-182
Total shareholders equity
150,662
224,241
225,001
204,253
Total liabilities and shareholders equity
640,678
505,943
512,736
490,610
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.